Aegle Therapeutics Corp
PrivateLast Round
Seed Round
Aug 4, 2026
Total Funding Raised
$7.1M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Aegle Therapeutics Corp operates in Healthcare & Life Sciences and is based in Miami, Florida. Its latest recorded funding round was a Grant round in October 2020.
Aegle Therapeutics Corp is a biotechnology company that develops a platform to isolate extracellular vesicles for treating burns and dermatological disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aegle Therapeutics Corp Comparables
Compare Aegle Therapeutics Corp with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Xinnate AB | 81% | |
| Phoenicis Therapeutics | 79% | |
| INTENT Biologics | 78% |
For institutional investors. Book with your work email.
Aegle Therapeutics Corp Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Aug 4, 2026 | ||||
| Seed Round | Dec 30, 2025 | ||||
| Convertible Debt | Dec 1, 2024 | ||||
| Grant | Oct 8, 2020 |
For institutional investors. Book with your work email.
Aegle Therapeutics Corp Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Tellus BioVentures | Grant |
| DeepWork Capital | Grant |
| U.S. Department of War | Grant |
| Ocean Azul Partners | Grant |
| New World Angels | Convertible Debt, Grant |
| DEFTA Partners | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 52% MoM.
- Aug 4, 2026
Raised $2.3M in Seed funding.
For institutional investors. Book with your work email.
Aegle Therapeutics Corp Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Aegle Therapeutics Corp's valuation, stock price, and market status.
Is Aegle Therapeutics Corp a public or private company?
Aegle Therapeutics Corp is a private company.
What is the current stock price of Aegle Therapeutics Corp?
Aegle Therapeutics Corp is a private company, so its shares have no public market price. Caplight tracks Aegle Therapeutics Corp's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Aegle Therapeutics Corp worth (valuation)?
Valuation information for Aegle Therapeutics Corp is not publicly available.
Can I buy Aegle Therapeutics Corp stock?
Aegle Therapeutics Corp shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Aegle Therapeutics Corp's last funding round?
Aegle Therapeutics Corp's most recent funding round was Seed Round on August 4, 2026.
Who are the main investors in Aegle Therapeutics Corp?
Key investors in Aegle Therapeutics Corp include New World Angels.
Will Aegle Therapeutics Corp IPO soon?
No public IPO plans have been announced for Aegle Therapeutics Corp.
How can I track Aegle Therapeutics Corp secondary market activity?
Caplight tracks bids, offers, and trades in Aegle Therapeutics Corp's shares on secondary markets.